Jiangzhong Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000M80
CNY
23.19
0.19 (0.83%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
942.14
1,166.55
1,444.58
786.42
930.46
1,255.74
1,153.19
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
942.14
1,166.55
1,444.58
786.42
930.46
1,255.74
1,153.19
Raw Material Cost
351.96
389.54
669.45
300.54
303.05
434.02
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.25
0.23
1.45
0.02
0.21
0.02
0.00
Selling and Distribution Expenses
270.46
445.68
532.92
316.82
354.45
473.76
0.00
Other Expenses
3.55
2.19
4.70
0.86
3.18
2.54
-0.61
Total Expenditure (Excl Depreciation)
658.13
857.40
1,250.79
626.02
689.47
933.24
-6.09
Operating Profit (PBDIT) excl Other Income
284
309.20000000000005
193.79999999999998
160.39999999999998
241
322.5
1159.3000000000002
Other Income
49.15
50.32
42.82
28.66
42.44
26.68
0.00
Operating Profit (PBDIT)
380.70
395.67
264.89
224.92
316.63
372.08
1,168.61
Interest
0.25
0.23
1.45
0.02
0.21
0.02
0.00
Exceptional Items
0.63
0.05
-9.47
0.00
0.22
0.62
0.00
Gross Profit (PBDT)
590.18
777.01
775.13
485.88
627.40
821.72
0.00
Depreciation
37.03
37.03
36.29
36.29
32.58
32.58
30.93
Profit Before Tax
344.05
358.46
217.67
188.61
284.05
340.10
0.00
Tax
91.52
52.30
41.44
28.25
43.91
51.01
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
237.42
284.91
153.85
145.59
221.97
269.02
115.97
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
237.42
284.91
153.85
145.59
221.97
269.02
115.97
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
15.30
21.78
22.76
13.89
17.90
19.92
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
252.72
306.70
176.61
159.47
239.87
288.94
115.97
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,946.03
4,148.19
3,862.81
3,717.86
3,885.59
4,099.55
3,831.52
Earnings per share (EPS)
0.38
0.45
0.25
0.23
0.35
0.43
0.0
Diluted Earnings per share
0.38
0.45
0.25
0.23
0.35
0.43
0.0
Operating Profit Margin (Excl OI)
31.26%
26.43%
12.86%
20.34%
25.97%
24.91%
98.65%
Gross Profit Margin
40.45%
33.9%
17.58%
28.6%
34.03%
29.68%
2.68%
PAT Margin
25.2%
24.42%
10.65%
18.51%
23.86%
21.42%
10.06%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is -19.24% vs -19.24% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is -17.61% vs 73.67% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is -4.02% vs 55.52% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is 50.00% vs -86.67% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

Compare Quarterly Results Of Jiangzhong Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
942.14
0
942.14
Other Operating Income
0.00
0.00
0.00
Total Operating income
942.14
0
942.14
Raw Material Cost
351.96
0
351.96
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.25
0
0.25
Selling and Distribution Expenses
270.46
0
270.46
Other Expenses
3.55
0.00
3.55
Total Expenditure (Excl Depreciation)
658.13
0
658.13
Operating Profit (PBDIT) excl Other Income
284.01
0.00
284.01
Other Income
49.15
0
49.15
Operating Profit (PBDIT)
380.70
0
380.70
Interest
0.25
0
0.25
Exceptional Items
0.63
0
0.63
Gross Profit (PBDT)
590.18
0
590.18
Depreciation
37.03
0
37.03
Profit Before Tax
344.05
0
344.05
Tax
91.52
0
91.52
Provisions and contingencies
0
0
0.00
Profit After Tax
237.42
0
237.42
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
237.42
0
237.42
Share in Profit of Associates
0
0
0.00
Minority Interest
15.30
0
15.30
Other related items
0.00
0.00
0.00
Consolidated Net Profit
252.72
0
252.72
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,946.03
0
3,946.03
Earnings per share (EPS)
0.38
0
0.38
Diluted Earnings per share
0.38
0
0.38
Operating Profit Margin (Excl OI)
31.26%
0%
0.00
31.26%
Gross Profit Margin
40.45%
0%
0.00
40.45%
PAT Margin
25.20%
0%
0.00
25.20%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 94.21 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -19.24% vs -19.24% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 1.25% vs -7.20% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 25.27 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -17.61% vs 73.67% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 5.34% vs 10.45% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 33.15 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -4.02% vs 55.52% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 20.90% vs 8.08% in Jun 2024

Quarterly - Interest
Interest 0.03 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 50.00% vs -86.67% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 50.00% vs -88.89% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.26%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024